|
Originally published In Press as doi:10.1074/jbc.M302216200 on April 28, 2003
J. Biol. Chem., Vol. 278, Issue 29, 26497-26504, July 18, 2003
Polymerization of Mycobacterial Arabinogalactan and Ligation to Peptidoglycan*
Tetsuya Yagi ,
Sebabrata Mahapatra,
Katarína Miku ová ,
Dean C. Crick and
Patrick J. Brennan ¶
From the
Department of Microbiology, Immunology and Pathology, Colorado State
University, Fort Collins, Colorado 80523-1682
The cell wall of Mycobacterium spp. consists predominately of
arabinogalactan chains linked at the reducing ends to peptidoglycan via a
P-GlcNAc-( 13)-Rha linkage unit (LU) and esterified to a variety
of mycolic acids at the nonreducing ends. Several aspects of the biosynthesis
of this complex have been defined, including the initial formation of the LU
on a polyprenyl phosphate (Pol-P) molecule followed by the sequential addition
of galactofuranosyl (Galf) units to generate
Pol-P-P-LU-(Galf)1,2,3, etc. and Pol-P-P-LU-galactan, catalyzed by
a bifunctional galactosyltransferase (Rv3808c) capable of adding alternating
5- and 6-linked Galf units. By applying cell-free extracts of
Mycobacterium smegmatis, containing cell wall and membrane fragments,
and differential labeling with UDP-[14C]Galp and
recombinant UDP-Galp mutase as the source of
[14C]Galf for galactan biosynthesis and
5-P-[14C]ribosyl-P-P as a donor of [14C]Araf
for arabinan synthesis, we now demonstrate sequential synthesis of the simpler
Pol-P-P-LU-(Galf)n glycolipid intermediates followed by
the Pol-P-P-LU-arabinogalactan and, finally, ligation of the
P-LU-arabinogalactan to peptidoglycan. This first time demonstration of in
vitro ligation of newly synthesized P-LU-arabinogalactan to newly
synthesized peptidoglycan is a necessary forerunner to defining the genetics
and enzymology of cell wall polymer-peptidoglycan ligation in
Mycobacterium spp. and examining this step as a target for new
antibacterial drugs.
Received for publication, March 4, 2003
, and in revised form, April 28, 2003.
* This work was supported by NIAID, National Institutes of Health, Grants
AI-18357 and AI-46393 (to P. J. B.) and AI-49151 (to D. C. C.). The costs of
publication of this article were defrayed in part by the payment of page
charges. This article must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section 1734
solely to indicate this fact.
Supported in part by the Japan Health Sciences Foundation. Present address:
Dept. of Bacterial Pathogenesis and Infection Control, National Institute of
Infectious Diseases, 4-7-1 Gakuen, Musashi-Murayama, Tokyo 208-0011,
Japan.
Present address: Dept. of Biochemistry, Faculty of Natural Sciences,
Comenius University, Mlynska dolina CH-1, Bratislava 842 15, Slovakia.
¶
To whom correspondence should be addressed. Tel.: 970-491-6700; Fax:
970-491-1815; E-mail:
Patrick.Brennan{at}ColoState.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Berg, D. Kaur, M. Jackson, and P. J Brennan
The glycosyltransferases of Mycobacterium tuberculosis--roles in the synthesis of arabinogalactan, lipoarabinomannan, and other glycoconjugates
Glycobiology,
June 1, 2007;
17(6):
35R - 56R.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Alderwick, L. G. Dover, M. Seidel, R. Gande, H. Sahm, L. Eggeling, and G. S. Besra
Arabinan-deficient mutants of Corynebacterium glutamicum and the consequent flux in decaprenylmonophosphoryl-D-arabinose metabolism
Glycobiology,
November 1, 2006;
16(11):
1073 - 1081.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Alderwick, E. Radmacher, M. Seidel, R. Gande, P. G. Hitchen, H. R. Morris, A. Dell, H. Sahm, L. Eggeling, and G. S. Besra
Deletion of Cg-emb in Corynebacterianeae Leads to a Novel Truncated Cell Wall Arabinogalactan, whereas Inactivation of Cg-ubiA Results in an Arabinan-deficient Mutant with a Cell Wall Galactan Core
J. Biol. Chem.,
September 16, 2005;
280(37):
32362 - 32371.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Mahapatra, T. Yagi, J. T. Belisle, B. J. Espinosa, P. J. Hill, M. R. McNeil, P. J. Brennan, and D. C. Crick
Mycobacterial Lipid II Is Composed of a Complex Mixture of Modified Muramyl and Peptide Moieties Linked to Decaprenyl Phosphate
J. Bacteriol.,
April 15, 2005;
187(8):
2747 - 2757.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Mahapatra, H. Scherman, P. J. Brennan, and D. C. Crick
N Glycolylation of the Nucleotide Precursors of Peptidoglycan Biosynthesis of Mycobacterium spp. Is Altered by Drug Treatment
J. Bacteriol.,
April 1, 2005;
187(7):
2341 - 2347.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Consaul, L. F. Wright, S. Mahapatra, D. C. Crick, and M. S. Pavelka Jr.
An Unusual Mutation Results in the Replacement of Diaminopimelate with Lanthionine in the Peptidoglycan of a Mutant Strain of Mycobacterium smegmatis
J. Bacteriol.,
March 1, 2005;
187(5):
1612 - 1620.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. B. Raymond, S. Mahapatra, D. C. Crick, and M. S. Pavelka Jr.
Identification of the namH Gene, Encoding the Hydroxylase Responsible for the N-Glycolylation of the Mycobacterial Peptidoglycan
J. Biol. Chem.,
January 7, 2005;
280(1):
326 - 333.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|